These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 29683843)

  • 1. Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ cell count at least 500 cells/μl.
    Kong CY; Sigel K; Criss SD; Sheehan DF; Triplette M; Silverberg MJ; Henschke CI; Justice A; Braithwaite RS; Wisnivesky J; Crothers K
    AIDS; 2018 Jun; 32(10):1333-1342. PubMed ID: 29683843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.
    de Koning HJ; Meza R; Plevritis SK; ten Haaf K; Munshi VN; Jeon J; Erdogan SA; Kong CY; Han SS; van Rosmalen J; Choi SE; Pinsky PF; Berrington de Gonzalez A; Berg CD; Black WC; Tammemägi MC; Hazelton WD; Feuer EJ; McMahon PM
    Ann Intern Med; 2014 Mar; 160(5):311-20. PubMed ID: 24379002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.
    Meza R; Jeon J; Toumazis I; Ten Haaf K; Cao P; Bastani M; Han SS; Blom EF; Jonas DE; Feuer EJ; Plevritis SK; de Koning HJ; Kong CY
    JAMA; 2021 Mar; 325(10):988-997. PubMed ID: 33687469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population impact of lung cancer screening in the United States: Projections from a microsimulation model.
    Criss SD; Sheehan DF; Palazzo L; Kong CY
    PLoS Med; 2018 Feb; 15(2):e1002506. PubMed ID: 29415013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
    Ten Haaf K; Tammemägi MC; Bondy SJ; van der Aalst CM; Gu S; McGregor SE; Nicholas G; de Koning HJ; Paszat LF
    PLoS Med; 2017 Feb; 14(2):e1002225. PubMed ID: 28170394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
    Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
    Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and efficacy of early lung cancer diagnosis with chest computed tomography in HIV-infected smokers.
    Makinson A; Eymard-Duvernay S; Raffi F; Abgrall S; Bommart S; Zucman D; Valour F; Cheret A; Poizot-Martin I; Duvivier C; Mauboussin JM; Bonnet F; Tattevin P; Reynes J; Le Moing V;
    AIDS; 2016 Feb; 30(4):573-82. PubMed ID: 26829006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chest Low-Dose Computed Tomography for Early Lung Cancer Diagnosis as an Opportunity to Diagnose Vertebral Fractures in HIV-Infected Smokers, an ANRS EP48 HIV CHEST Substudy.
    Thouvenin Y; Makinson A; Cournil A; Eymard-Duvernay S; Lentz P; Delemazure AS; Corneloup O; Fabre S; Quesnoy M; Poire S; Brillet PY; Cyteval C; Reynes J; Le Moing V;
    J Acquir Immune Defic Syndr; 2015 Jul; 69(3):299-305. PubMed ID: 26058045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying Patients for Whom Lung Cancer Screening Is Preference-Sensitive: A Microsimulation Study.
    Caverly TJ; Cao P; Hayward RA; Meza R
    Ann Intern Med; 2018 Jul; 169(1):1-9. PubMed ID: 29809244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Inclusion of More Black Individuals in Lung Cancer Screening With Reduced Mortality.
    Prosper AE; Inoue K; Brown K; Bui AAT; Aberle D; Hsu W
    JAMA Netw Open; 2021 Aug; 4(8):e2119629. PubMed ID: 34427681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerating integration of tobacco use treatment in the context of lung cancer screening: Relevance and application of implementation science to achieving policy and practice.
    Shelley D; Wang VH; Taylor K; Williams R; Toll B; Rojewski A; Foley KL; Rigotti N; Ostroff JS
    Transl Behav Med; 2022 Nov; 12(11):1076-1083. PubMed ID: 36227937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Findings in asymptomatic HIV-infected patients undergoing chest computed tomography testing: implications for lung cancer screening.
    Sigel K; Wisnivesky J; Shahrir S; Brown ST; Justice A; Kim J; Rodriguez-Barradas MC; Akgün KM; Rimland D; Hoo GW; Crothers K
    AIDS; 2014 Apr; 28(7):1007-14. PubMed ID: 24401647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
    Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M;
    Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of Low-Dose Computed Tomography With a Plasma-Based Biomarker for Lung Cancer Screening in China.
    Zhao Z; Wang Y; Wu W; Yang Y; Du L; Dong H
    JAMA Netw Open; 2022 May; 5(5):e2213634. PubMed ID: 35608858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of overdiagnosis on the selection of efficient lung cancer screening strategies.
    Han SS; Ten Haaf K; Hazelton WD; Munshi VN; Jeon J; Erdogan SA; Johanson C; McMahon PM; Meza R; Kong CY; Feuer EJ; de Koning HJ; Plevritis SK
    Int J Cancer; 2017 Jun; 140(11):2436-2443. PubMed ID: 28073150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Lung Cancer Screening Eligibility Using Simplified Criteria.
    Triplette M; Donovan LM; Crothers K; Madtes DK; Au DH
    Ann Am Thorac Soc; 2019 Oct; 16(10):1280-1285. PubMed ID: 31298946
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load.
    Asgari MM; Ray GT; Quesenberry CP; Katz KA; Silverberg MJ
    JAMA Dermatol; 2017 Sep; 153(9):892-896. PubMed ID: 28700773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung Cancer Screening.
    Hoffman RM; Sanchez R
    Med Clin North Am; 2017 Jul; 101(4):769-785. PubMed ID: 28577626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort.
    Hleyhel M; Hleyhel M; Bouvier AM; Belot A; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
    AIDS; 2014 Sep; 28(14):2109-18. PubMed ID: 25265077
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.